Moexipril

Major

Moexipril Aspirin Acuprin® Reduced hyponatremic and hypotensive effects of ACE inhibitors Details Moexipril Aspirin Rectal Aspirin Reduced hyponatremic and hypotensive effects of ACE inhibitors Details Moexipril Azathioprine Azasan Myelosuppression Details Moexipril Azilsartan Edarbi Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Moexipril Cyclosporine Injection Atopica Acute renal dysfunction and an increased risk of hyperkalemia Details Moexipril Cyclosporine Ophthalmic Cequa Acute renal dysfunction and an increased risk of hyperkalemia Details Moexipril Digoxin Cardoxin® An increased digoxin exposure Details Moexipril Eprosartan Teveten® Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Moexipril Everolimus Afinitor Increased risk of angioedema Details Moexipril Furosemide Injection Disal An increased risk of severe hypotension and deterioration in renal function, including renal failure Details Moexipril Irbesartan Avapro Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Moexipril Lithium Carbonate Lithobid Increased risk of lithium toxicity Details Moexipril Losartan Arbli Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Moexipril Melphalan Alkeran An increased risk of severe hypotension Details Moexipril Melphalan Injection Alkeran An increased risk of severe hypotension Details Moexipril Mercaptopurine Purinethol® Myelosuppression Details Moexipril Alteplase, Recombinant Activase An increased risk of orolingual angioedema Details Moexipril Amiloride Increased risk of hyperkalemia Details Moexipril Azilsartan Medoxomil Edarbi Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Moexipril Candesartan Atacand Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Moexipril Canrenoate Increased risk of hyperkalemia Details Moexipril Cyclosporine Atopica Acute renal dysfunction and an increased risk of hyperkalemia Details Moexipril Eplerenone Inspra Increased risk of hyperkalemia Details Moexipril Furosemide Disal An increased risk of severe hypotension and deterioration in renal function, including renal failure Details Moexipril Insulin Icodec-Abae Awiqli An increased risk of hypoglycemia Details Moexipril Lithium Increased risk of lithium toxicity Details Moexipril Olmesartan Benicar Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Moexipril Potassium Glu-K® Hyperkalemia Details Moexipril Potassium Citrate Urocit-K Increased risk of hyperkalemia Details Moexipril Potassium Phosphate K-Phos Increased risk of severe and potentially fatal hyperkalemia Details Moexipril Pregabalin Bonqat Increased risk of angioedema Details Moexipril Sirolimus Felycin Increased risk of angioedema Details Moexipril Spironolactone Aldactone Increased risk of hyperkalemia Details Moexipril Tacrolimus Astagraf An increased risk of hyperkalemia Details Moexipril Telmisartan Micardis Increased risk of adverse events (ie, hypotension, syncope, hyperkalemia, changes in renal function, acute renal failure) Details Moexipril Temsirolimus Torisel Increased risk of angioedema Details Moexipril Triamterene Dyrenium Increased risk of hyperkalemia Details Moexipril Trimethoprim Primsol Increased risk of hyperkalemia Details